Published in
Elsevier, Cancer Treatment Reviews, (111), p. 102465, 2022
DOI: 10.1016/j.ctrv.2022.102465
Links
Tools
Response to “Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias”
Journal article published in 2022 by
Guillermo Villacampa,
Alberto Hernando-Calvo 
,
Roger Berché,
Omar Saavedra,
David Marmolejo,
Oriol Mirallas,
Irene Braña,
Eva Muñoz-Couselo,
Elena Garralda ,
Rodrigo Dienstmann
,
Roger Berché,
Omar Saavedra,
David Marmolejo,
Oriol Mirallas,
Irene Braña,
Eva Muñoz-Couselo,
Elena Garralda ,
Rodrigo Dienstmann
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 